Elevation Oncology (NASDAQ:ELEV) Upgraded at SVB Leerink

SVB Leerink upgraded shares of Elevation Oncology (NASDAQ:ELEV – Get Rating) from a market perform rating to an outperform rating in a research report report published on Tuesday morning, PriceTargets.com reports. A number of other analysts have also recently issued reports on ELEV. Wedbush restated an outperform rating and set a $4.00 price objective on […]

Related Keywords

United States , ,Tang Capital Management ,Elevation Oncology Inc ,Sio Capital Management ,Geode Capital Management ,Renaissance Technologies ,Elevation Oncology ,Get Rating ,Moderate Buy ,Oncology Stock Down ,Capital Management ,Sigma Investments ,Elevation Oncology Daily ,Nasdaq Elev ,Belev ,Medical ,Upgrade ,Svb Leerink Llc ,